ArticleActa oncologica (Stockholm, Sweden)2026

A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma.

Suweydo Abdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.